Polyplus-transfection
About:
Polyplus-transfection develops, markets and sells solutions for the delivery of nucleic acids in research, bioproduction and therapeutics.
Website: http://www.polyplus-transfection.com
Twitter/X: polyplus_transf
Top Investors: Crédit Mutuel Innovation, CIC Finance, Sudinnova
Description:
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.
2.5M EUR
$1M to $10M
Illkirch-graffenstaden, Alsace, France
2001-01-01
Anne Monjanel, Joelle Bloch, Patrick Metz, Paul Behr
11-50
2011-01-11
Private
© 2025 bioDAO.ai